Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
21 08 2020
Historique:
received: 19 03 2019
revised: 28 02 2020
accepted: 23 06 2020
entrez: 22 8 2020
pubmed: 21 8 2020
medline: 22 9 2020
Statut: ppublish

Résumé

Intestinal microbiota have been proposed to induce commensal-specific memory T cells that cross-react with tumor-associated antigens. We identified major histocompatibility complex (MHC) class I-binding epitopes in the tail length tape measure protein (TMP) of a prophage found in the genome of the bacteriophage

Identifiants

pubmed: 32820119
pii: 369/6506/936
doi: 10.1126/science.aax0701
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antigens, Neoplasm 0
Antineoplastic Agents, Alkylating 0
Epitopes 0
H-2 Antigens 0
H-2Kb protein, mouse 0
Histocompatibility Antigens Class I 0
Programmed Cell Death 1 Receptor 0
Viral Tail Proteins 0
Cyclophosphamide 8N3DW7272P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

936-942

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Aurélie Fluckiger (A)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.

Romain Daillère (R)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.
everImmune, Gustave Roussy Cancer Center, Villejuif, France.

Mohamed Sassi (M)

Université Rennes 1, Laboratoire de Biochimie Pharmaceutique, Inserm U1230 - UPRES EA 2311, Rennes, France.

Barbara Susanne Sixt (BS)

Laboratory for Molecular Infection Medicine Sweden, Umeå Centre for Microbial Research, Department of Molecular Biology, Umeå University, 90187, Umeå, Sweden.
Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
INSERM U1138, Paris, France.
Université de Paris, Paris, France.
Sorbonne Université, Paris, France.

Peng Liu (P)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
INSERM U1138, Paris, France.
Université de Paris, Paris, France.
Sorbonne Université, Paris, France.

Friedemann Loos (F)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
INSERM U1138, Paris, France.
Université de Paris, Paris, France.
Sorbonne Université, Paris, France.

Corentin Richard (C)

Research Platform in Biological Oncology, Dijon, France.
GIMI Genetic and Immunology Medical Institute, Dijon, France.
University of Burgundy-Franche Comté, Dijon, France.

Catherine Rabu (C)

CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
LabEx IGO "Immunotherapy, Graft, Oncology," Nantes, France.

Maryam Tidjani Alou (MT)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.
UMR MEPHI, Aix-Marseille Université, IRD, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille cedex 05, France.

Anne-Gaëlle Goubet (AG)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.

Fabien Lemaitre (F)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
everImmune, Gustave Roussy Cancer Center, Villejuif, France.

Gladys Ferrere (G)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.

Lisa Derosa (L)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.
Université Paris-Saclay, Villejuif, F-94805, France.

Connie P M Duong (CPM)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.

Meriem Messaoudene (M)

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Research Center and Department of Cytology and Pathology, Québec City, Québec, Canada.

Andréanne Gagné (A)

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Research Center and Department of Cytology and Pathology, Québec City, Québec, Canada.

Philippe Joubert (P)

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Research Center and Department of Cytology and Pathology, Québec City, Québec, Canada.

Luisa De Sordi (L)

Bacteriophage, Bacterium, Host Laboratory, Institut Pasteur, F-75015 Paris, France.
Sorbonne Université, Centre de Recherche Saint Antoine, INSERM UMRS_938, Paris, France.

Laurent Debarbieux (L)

Bacteriophage, Bacterium, Host Laboratory, Institut Pasteur, F-75015 Paris, France.

Sylvain Simon (S)

CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
LabEx IGO "Immunotherapy, Graft, Oncology," Nantes, France.

Clara-Maria Scarlata (CM)

Cancer Research Centre of Toulouse, INSERM UMR 1037, 31037 Toulouse, France; Université Toulouse III Paul Sabatier, 31330 Toulouse, France; Institut Universitaire du Cancer de Toulouse-Oncopole, 31100 Toulouse, France.

Maha Ayyoub (M)

Cancer Research Centre of Toulouse, INSERM UMR 1037, 31037 Toulouse, France; Université Toulouse III Paul Sabatier, 31330 Toulouse, France; Institut Universitaire du Cancer de Toulouse-Oncopole, 31100 Toulouse, France.

Belinda Palermo (B)

Unit of Tumor Immunology and Immunotherapy, Department of Research, Advanced Diagnostics and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Francesco Facciolo (F)

Thoracic Surgery Unit, Department of Surgical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Romain Boidot (R)

Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.

Richard Wheeler (R)

Institut Pasteur, Unit Biology and Genetics of the Bacterial Cell Wall, Paris, France.

Ivo Gomperts Boneca (IG)

Institut Pasteur, Unit Biology and Genetics of the Bacterial Cell Wall, Paris, France.

Zsofia Sztupinszki (Z)

Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA.

Krisztian Papp (K)

Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.

Istvan Csabai (I)

Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.

Edoardo Pasolli (E)

Department of Agricultural Sciences, University of Naples Federico II, Naples, Italy.

Nicola Segata (N)

Department CIBIO, University of Trento, Trento, Italy.

Carlos Lopez-Otin (C)

Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
INSERM U1138, Paris, France.
Université de Paris, Paris, France.
Sorbonne Université, Paris, France.
Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain.

Zoltan Szallasi (Z)

Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Danish Cancer Society Research Center, Copenhagen, Denmark.
MTA-SE-NAP, Brain Metastasis Research Group, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.

Fabrice Andre (F)

Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France.
INSERM Unit 981, Gustave Roussy, Villejuif, France.

Valerio Iebba (V)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.
Department of Medical Sciences, University of Trieste, 34137 Trieste, Italy.

Valentin Quiniou (V)

AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center in Biotherapy (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), F-75651, Paris, France.
Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), F-75651, Paris, France.

David Klatzmann (D)

AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center in Biotherapy (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), F-75651, Paris, France.
Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), F-75651, Paris, France.

Jacques Boukhalil (J)

UMR MEPHI, Aix-Marseille Université, IRD, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille cedex 05, France.

Saber Khelaifia (S)

UMR MEPHI, Aix-Marseille Université, IRD, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille cedex 05, France.

Didier Raoult (D)

UMR MEPHI, Aix-Marseille Université, IRD, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille cedex 05, France.

Laurence Albiges (L)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Department of Medical Oncology, Gustave Roussy, Villejuif, France.

Bernard Escudier (B)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Department of Medical Oncology, Gustave Roussy, Villejuif, France.
INSERM U981, GRCC, Villejuif, France.

Alexander Eggermont (A)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
Princess Maxima Center, CS 3584 Utrecht, the Netherlands.

Fathia Mami-Chouaib (F)

INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine - Univ. Paris-Sud, Université Paris-Saclay, 94805, Villejuif, France.

Paola Nistico (P)

Unit of Tumor Immunology and Immunotherapy, Department of Research, Advanced Diagnostics and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Thoracic Surgery Unit, Department of Surgical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

François Ghiringhelli (F)

Department of Medical Oncology, Center GF Leclerc, Dijon, France.

Bertrand Routy (B)

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Research Center and Department of Cytology and Pathology, Québec City, Québec, Canada.
Division d'Hémato-Oncologie, Département de Médicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.

Nathalie Labarrière (N)

CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
LabEx IGO "Immunotherapy, Graft, Oncology," Nantes, France.

Vincent Cattoir (V)

Université Rennes 1, Laboratoire de Biochimie Pharmaceutique, Inserm U1230 - UPRES EA 2311, Rennes, France.
CHU de Rennes - Hôpital Ponchaillou, Service de Bactériologie-Hygiène Hospitalière, Rennes, France.
CNR de la Résistance aux Antibiotiques (laboratoire associé 'Entérocoques'), Rennes, France.

Guido Kroemer (G)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France. laurence.zitvogel@gustaveroussy.fr kroemer@orange.fr.
Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
INSERM U1138, Paris, France.
Université de Paris, Paris, France.
Sorbonne Université, Paris, France.
Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Department of Women's and Children's Health, Karolinska University Hospital, 1 Stockholm, Sweden.
Suzhou Institute for Systems Biology, Chinese Academy of Medical Sciences, Suzhou, China.
Institut Universitaire de France, Paris, France.

Laurence Zitvogel (L)

Gustave Roussy Cancer Campus (GRCC), Villejuif, France. laurence.zitvogel@gustaveroussy.fr kroemer@orange.fr.
Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.
Université Paris-Saclay, Villejuif, F-94805, France.
Suzhou Institute for Systems Biology, Chinese Academy of Medical Sciences, Suzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH